...
首页> 外文期刊>Journal of Molecular Structure >Pharmacologically significant complexes of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II) of novel Schiff base ligand, (E)-N-(furan-2-yl methylene) quinolin-8-amine: Synthesis, spectral, XRD, SEM, antimicrobial, antioxidant and in vitro cytotoxic studies
【24h】

Pharmacologically significant complexes of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II) of novel Schiff base ligand, (E)-N-(furan-2-yl methylene) quinolin-8-amine: Synthesis, spectral, XRD, SEM, antimicrobial, antioxidant and in vitro cytotoxic studies

机译:新型席夫碱配体(E)-N-(呋喃-2-基亚甲基)喹啉-的Mn(II),Co(II),Ni(II),Cu(II)和Zn(II)的重要药理复合物8-胺:合成,光谱,XRD,SEM,抗微生物,抗氧化剂和体外细胞毒性研究

获取原文
获取原文并翻译 | 示例
           

摘要

A novel series of metal complexes of the types, [ML2(H2O)(2)]Cl-2 and [ML2]Cl-2 [M = Mn(II), 1; Co(II), 2; Ni(II), 3; Cu(II), 4; and Zn(II), 5] were synthesized by the interaction of ligand, L (E)-N-(furan-2-yl methylene) quinolin-8-amine, derived from the condensation of 2-furaldehyde and 8-aminoquinoline. The synthesized ligand and its metal complexes were characterized on the basis of results obtained from elemental analysis, ESI-MS, XRD, SEM, TGA/DTA, FT-IR, UV-Vis, magnetic moment and H-1 and C-13 NMR spectroscopic studies. EPR parameters were recorded in case of complex 4. The comparative in-vitro antimicrobial activities against various pathogens with reference to known antibiotics and antioxidant activity against standard control at variable concentrations revealed that the metal complexes show enhanced antimicrobial and free radical scavenging activities in general as compared to free ligand. However, the complexes 1 and 5 have shown best antioxidant activity among all the metal complexes. Furthermore, comparative in-vitro antiproliferative activity on ligand and its metal chelates performed on MDA-MB-231 (breast carcinoma), KCL22 (blood lymphoid carcinoma), HeLa (cervical carcinoma) cell lines and normal cells (PBMC) revealed that metal chelates show moderate to good activity as compared to ligand where as complex 1 seems to be the most promising one possessing a broad spectrum of activity against all the selected cancer cell lines with IC50 < 2.10 mu M. (C) 2015 Elsevier B.V. All rights reserved.
机译:[ML2(H2O)(2)] Cl-2和[ML2] Cl-2类型的一系列新颖的金属配合物[M = Mn(II),1; Co(II),2; Ni(II),3;铜(II),4; Zn(II)和Zn(II),5]是由配位体L(E)-N-(呋喃-2-基亚甲基)喹啉-8-胺与2-呋喃醛和8-氨基喹啉缩合而合成的。根据元素分析,ESI-MS,XRD,SEM,TGA / DTA,FT-IR,UV-Vis,磁矩以及H-1和C-13 NMR获得的结果对合成的配体及其金属配合物进行表征光谱学研究。在配合物4的情况下,记录了EPR参数。参考已知抗生素对各种病原体的体外抗微生物活性比较,以及在可变浓度下对标准对照的抗氧化活性表明,金属配合物通常具有增强的抗菌和自由基清除活性。与游离配体相比。然而,在所有金属配合物中,配合物1和5显示出最佳的抗氧化活性。此外,在MDA-MB-231(乳腺癌),KCL22(淋巴样癌),HeLa(宫颈癌)细胞系和正常细胞(PBMC)上对配体及其金属螯合物进行的体外抗增殖活性比较表明,金属螯合物与配体相比显示出中等至良好的活性,而配体1似乎是最有前途的,对所有选定的癌细胞系均具有广泛的活性,IC50 <2.10μM。(C)2015 Elsevier BV保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号